| Company |
 |
Description |
|
Status |
![]() |
![]() |
![]() |
 |
|
Activate Networks applies social networks analytics to influence behavior of healthcare providers and patients to enhance wellness
|
|
Private |
 |
|
Aileron Therapeutics is developing Stapled Peptides, an entirely new therapeutic modality that can target all human diseases
|
|
Private |
|
|
Aventura has developed and is selling disruptive technology that dramatically increases the efficiency and effectiveness of doctors and nurses
by offering context and location aware computing with virtually instantaneous logins while providing the high level of security demanded in healthcare |
|
Private |
|
|
|
|
|
 |
|
BIOCIUS Life Sciences provides the biopharmaceutical industry with mass spectrometer related products to accelerate drug discovery and development |
|
Acquired by Agilent Technologies (A) in 2011 |
 |
|
BioTrove provides micro- and nano-scale technologies to serve research and diagnostics markets in healthcare and beyond
|
|
Acquired by Life Technologies (LIFE) in 2009
|
 |
|
Catch is a leading developer of smartphone and web productivity applications that capture, organize, and share information
|
|
Private |
 |
|
Cleveland HeartLab, Inc. is a speciality clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests
|
|
Private |
 |
|
Fina Technologies applies genomics-derived supercomputing and machine learning technologies to finance and other markets struggling with large data sets |
|
Private |
 |
|
IlluminOss Medical is a privately held medical device company dedicated to
bringing minimally invasive solutions for the stabilization and treatment of
bone fractures to market |
|
Private |
 |
|
Lantos Technologies is working to commercialize 3D digital scanner capable of measuring ear canal shape and tissue compliance |
|
Private |
 |
|
MedVentive works with leading provider and payer organizations to develop and deploy innovative, clinically sophisticated approaches to successfully reduce healthcare costs and improve the quality of patient care
|
|
Acquired by McKesson (MCK) in 2012 |
 |
|
nanoMR has developed the first system for rapid isolation of rare cells from
complex matrices that can target multiple cell types simultaneously |
|
Private |
 |
|
PathoGenetix, Inc. (formerly U.S. Genomics) is developing an automated system
for identification and strain typing of pathogens in a broad range of complex
sample types. |
|
Private |
 |
|
Saladax is a personalized medicine diagnostics company that has developed technology for dose management of chemotherapy agents |
|
Private |
 |
|
Shape Up helps people improve their health and wellness by harnessing the power of social networks, peer-to-peer support, motivation, and accountability |
|
Private |
 |
|
SGI is engineering microorganisms to address energy, agriculture, chemicals, pharmaceuticals and other applications |
|
Private |
 |
|
Tetraphase Pharmaceuticals is developing a portfolio of next generation antibiotics using its synthetic chemistry platform to create novel tetracyclines that address the global threat of antibiotic resistant infectious diseases |
|
Public (TTPH)
|
![]() |
![]() |
|
|
|
|
|
